2022 update of the drug resistance mutations in HIV-1
Publication date
2022-10-01
Authors
Wensing, Anne(marie)
Calvez, Vincent
Ceccherini-Silberstein, Francesca
Charpentier, Charlotte
Günthard, Huldrych F.
Paredes, Roger
Shafer, Robert W.
Richman, Douglas D.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.
Keywords
HIV, antiretroviral, drug resistance, TAM, therapy, mutations, Taverne, General Medicine
Citation
Wensing, A M, Calvez, V, Ceccherini-Silberstein, F, Charpentier, C, Günthard, H F, Paredes, R, Shafer, R W & Richman, D D 2022, '2022 update of the drug resistance mutations in HIV-1', Topics in Antiviral Medicine, vol. 30, no. 4, pp. 559-574. < https://www.iasusa.org/resources/hiv-drug-resistance-mutations/ >